Search


 
Results 1 - 10 of about 64 for "From ACP Journal Club".

Exenatide did not reduce major cardiovascular outcomes in ...

While exenatide can be considered a second-line option for patients with type 2 diabetes and some may prefer its once-weekly dosing, those at high ...

Liraglutide reduced a composite renal outcome at a median 4 ...

An ACP Journal Club commentary noted that the mechanism by which liraglutide improves renal outcomes is uncertain and that renal benefit was ...

In patients with type 2 diabetes and CV disease, empagliflozin ...

An industry-funded trial found that those who took empagliflozin had lower rates of mortality, including from cardiovascular (CV) events, than those on ...

In type 1 diabetes, education with either insulin pumps or daily ...

The results showed that when patients on multiple daily insulin injections received structured education, there was no additional benefit of switching ...

Review: In diabetes, intensive and standard glycemic control ...

The review suggests that treating diabetes with strict glycemic control does not reduce mortality or cardiovascular risk or slow progression of kidney disease ...

Self-monitoring of blood glucose did not improve HbA1c or ...

The randomized controlled trial adds to the evidence about routine use of self-monitoring of blood glucose for all patients with type 2 diabetes, according ...

Safety of dipeptidyl peptidase-4 inhibitors analyzed in 2 ...

A meta-analysis of dipeptidyl peptidase-4 inhibitors showed no increase in pancreatic adverse events, while a trial of saxagliptin found no effect on the ...

Gastric bypass or biliopancreatic diversion increases ...

A randomized controlled trial (RCT) of 60 severely obese adults with type 2 diabetes found that gastric bypass or biliopancreatic diversion increased ...

An intensive lifestyle intervention increased remission from ...

In the randomized, controlled Look AHEAD trial, an intensive lifestyle intervention (ILI) was associated with partial remission of type 2 diabetes when ...

Review: Metformin is linked to reduced mortality in type 2 ...

The included studies focused on metformin use in patients with chronic kidney disease (CKD), congestive heart failure (CHF), chronic liver disease (CLD ...

Result Page: 1 2 3 4 5  Next >